ArticleQuantitative imaging in medicine and surgery2024
Multi-scale perceptual modulation network for low-dose computed tomography denoising.
Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low-dose computed tomography (LDCT) reduces radiation exposure, but the introduced noise and artifacts impair its diagnostic accuracy. Convolutional neural networks (CNNs) are widely used for LDCT denoising, but they suffer from a limited receptive field. The use of a larger kernel size can enlarge the receptive field and boost model performance; however, the computational cost of the model greatly increases. We aimed to develop a LDCT denoising CNN with a large receptive field and lower computational complexity. Methods: We developed a multi-scale perceptual modulation network (MSPMnet) incorporating a powerful multi-head decomposable convolution (MHDC). To address the high computational complexity of large kernel convolutions, we developed a novel MHDC module that can capture multi-scale features and efficiently expand the receptive field. The MHDC module couples maximum-pooling with three depth-wise convolutions of varying kernel sizes via a channel splitting mechanism, where, unlike conventional CNNs, the two large two-dimensional kernels are each decomposed into a set of cascaded orthogonal one-dimensional kernels to remain lightweight. Further, departing from prior methodologies that apply a uniform kernel size throughout the network, we introduced a receptive field-ramp mechanism that adeptly transitions from local to relatively long-range dependency modeling as the network depth increases, thereby achieving superior performance. Results: The proposed MSPMnet was evaluated on a Mayo Clinic data set with a conventional iterative algorithm, two CNN models, and two Transformer models used for comparison. Compared to the competing baseline methods, the MSPMnet exhibited better performance in both the visual and quantitative assessments. Visually, the MSPMnet preserved the structure, edges, and textures with excellent noise and artifact reduction, generating the denoised images closest to normal-dose computed tomography images. Quantitatively, the MSPMnet had the lowest root mean-square error (RMSE) (8.3094±1.9325) and the highest peak signal-to-noise ratio (PSNR) (33.8525±1.8213 dB), structural similarity index (SSIM) (0.9309±0.0272), and feature similarity index (FSIM) (0.9699±0.0113), demonstrating superior denoising performance. Conclusions: The proposed MSPMnet excelled at LDCT denoising, effectively removing noise and artifacts while preserving edges. Compared to the state-of-the-art CNNs and Transformers, the proposed MSPMnet exhibited superior denoising performance both quantitatively and qualitatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.